Prognosis of vertebrobasilar transient ischaemic attack and minor stroke

Brain

Volumn 126, Issue 9, 2003, Pages 1940-1954

  Floßmann, Enrico ^a   Rothwell, Peter M ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Cerebral ischaemia; Posterior circulation; Prognosis; Transient; Vertebrobasilar

Indexed keywords

ADULT; AGED; BRAIN CIRCULATION; BRAIN ISCHEMIA; DISEASE SEVERITY; FEMALE; GENETIC HETEROGENEITY; HIGH RISK PATIENT; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK; TRANSITIONAL BLINDNESS; VERTEBROBASILAR INSUFFICIENCY;

EID: 0041320817     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/awg197     Document Type: Review

References (95)

1. Acheson J. Factors affecting the natural history of "focal cerebral vascular disease". Q J Med 1971; 40: 25-46.
2. Acheson J, Hutchinson EC. Observations on the natural history of transient cerebral ischaemia. Lancet 1964; ii: 871-4.
3. Ad Hoc Committee National Institute of Neurological and Communicative Disorders and Stroke. A classification and outline of cerebrovascular diseases. II. Stroke 1975; 6: 564-616.
4. Baker RN. Prospective study of transient ischemic attacks. In: Toole JF, Moossy J, Janeway R, editors. Cerebral vascular diseases. New York: Grune & Stratton; 1971. p. 166-9.
5. Baker RN, Schwartz WS, Rose AS. Transient ischemic strokes. A report of a study of anticoagulant therapy. Neurology 1966; 16: 841-7.
6. Baker RN, Ramseyer JC, Schwartz WS. Prognosis in patients with transient cerebral ischemic attacks. Neurology 1968; 18: 1157-65.
7. Baumgartner Ch, Zeiler K, Oder W, Binder H, Deecke L. Prognostische Faktoren für Langzeitmortalität und Schlaganfallrisiko bei Patienten mit transitorischen ischämischen Attacken. Wien Klin Wochenschr 1989; 101: 160-6.
8. Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJ, Meldrum H. Prognosis after transient monocular blindness associated with carotid-artery stenosis. New Engl J Med 2001; 345: 1084-90.
9. Biller J, Bruno A, Adams HP Jr, Godersky JC, Loftus CM, Mitchell VL, et al. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study. Stroke 1989; 20: 441-7.
10. Bousser MG, Eschwege E, Haguenau M, Lefauconnier JM, Thibult N, Touboul D, et al. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke 1983; 14: 5-14.
11. Bradshaw P, McQuaid P. The syndrome of vertebrobasilar insufficiency. Q J Med 1963; 32: 279-96.
12. Burén A, Ygge J. Treatment program and comparison between anticoagulants and platelet aggregation inhibitors after transient ischemic attack. Stroke 1981; 12: 578-80.
13. Calandre L, Molina JA. Short-term outcome of medically treated patients with transient ischemic attacks, reversible ischemic neurologic deficits and strokes with minimum residuum. Eur Neurol 1985; 24: 281-5.
14. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. New Engl J Med 1978; 299: 53-9.
15. Candelise L, Albanese V, Bono G, Brambilla L, De Zanche L, Inzitari D, et al. Prognosis of treated recent reversible ischemic attacks (RIAs): analysis of recurrence of RIAs, stroke and death according to the pathogenesis, angiographic findings, and risk factors. Pathol Biol 1982; 30: 621-4.
16. Candelise L, Vigotti M, Fieschi C, Brambilla GL, Bono G, Conforti P, et al. Italian Multicenter Study on reversible cerebral ischemic attacks: VI - Prognostic factors and follow-up results. Stroke 1986; 17: 842-8.
17. Caplan LR. Posterior circulation disease. Cambridge (MA): Blackwell Science; 1996. p. 20-1.
18. Caplan L. Posterior circulation ischemia: then, now, and tomorrow. The Thomas Willis Lecture - 2000. Stroke 2000; 31: 2011-23.
19. Carolei A, Candelise L, Fiorelli M, Francucci BM, Motolese M, Fieschi C. Long-term prognosis of transient ischemic attacks and reversible ischemic neurologic deficits: a hospital-based study. Cerebrovasc Dis 1992; 2: 266-72.
20. Cartlidge NE, Whisnant JP, Elveback LR. Carotid and vertebral-basilar transient cerebral ischemic attacks. A community study, Rochester, Minnesota. Mayo Clin Proc 1977; 52: 117-20.
21. Check WA. Predicting outcome for stroke, TIA patients. JAMA 1982; 247: 2080.
22. Cillessen JPM, Kappelle LJ, van Swieten JC, Algra A, van Gijn J. Does cerebral infarction after a previous warning occur in the same vascular territory? Stroke 1993; 24: 351-4.
23. Coull A, Silver L, Rothwell PM. Implications of rates of non fatal acute cerebrovascular versus coronary vascular events for provision of acute services: Oxford Vascular Study (OXVASC). Cerebrovasc Dis 2003; 16(54): 1-2.
24. Culebras A, Kase CS, Masdeu JC, Fox AJ, Bryan RN, Grossman CB, et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of the Stroke Council, American Heart Association. Stroke 1997; 28: 1480-97.
25. Davenport RJ, Dennis MS, Warlow CP. The accuracy of Scottish Morbidity Record (SMR1) data for identifying hospitalised stroke patients. Health Bull (Edinb) 1996; 54: 402-5.
26. David NJ, Heyman A. Factors influencing the prognosis of cerebral thrombosis and infarction due to atherosclerosis. J Chron Dis 1960; 11: 394-404.
27. Dennis M, Bamford J, Sandercock P, Warlow C. A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project. Stroke 1989; 20: 1494-9.
28. Dennis M, Bamford J, Sandercock P, Molyneux A, Warlow C. Computed tomography in patients with transient ischaemic attacks: when is a transient ischaemic attack not a transient ischaemic attack but a stroke? J Neurol 1990a; 237: 257-61.
29. Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990b; 21: 848-53.
30. Drake WE Jr, Drake MAL. Clinical and angiographic correlates of cerebrovascular insufficiency. Am J Med 1968; 45: 253-70.
31. Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. New Engl J Med 1991; 325: 1261-6.
32. Dutch TIA Trial Study Group. Predictors of major vascular events in patients with a transient ischemic attack or nondisabling stroke. Stroke 1993; 24: 527-31.
33. Dyken ML, Conneally M, Haerer AF, Gotshall RA, Calanchini PR, Poskanzer DC, et al. Cooperative study of hospital frequency and character of transient ischemic attacks. I. Background, organization, and clinical survey. JAMA 1977; 237: 882-6.
34. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
35. Eriksson S-E. Enteric-coated acetylsalicylic acid plus dipyridamol compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks. Acta Neurol Scand 1985; 71: 485-93.
36. ESPS Group. European Stroke Prevention Study. Stroke 1990; 21: 1122-30.
37. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-54.
38. Fieschi C, Argentino C, Rasura M. Italian study of reversible ischemic attacks. Stroke 1981; 12: 293-5.
39. Friedman GD, Wilson WS, Mosier JM, Colandrea MA, Nichaman MZ. Transient ischemic attacks in a community. JAMA 1969; 210: 1428-34.
40. Gent M, Barnett HJ, Sackett DL, Taylor DW. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodological issues. Circulation 1980; 62 (6 Pt 2): V97-105.
41. Grotta JC, Norris JW, Kamm B. Prevention of stroke with ticlopidine: who benefits most? TASS Baseline and Angiographic Data Subgroup. Neurology 1992; 42: 111-5.
42. Haerer AF, Gotshall RA, Conneally PM, Dyken ML, Poskanzer DC, Price TR, et al. Cooperative study of hospital frequency and character of transient ischemic attacks. III. Variations in treatment. JAMA 1977; 238: 142-6.
43. Hankey GJ, Slattery JM, Warlow CP. The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry 1991; 54: 793-802.
44. Hankey GJ, Slattery JM, Warlow CP. Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? J Neurol Neurosurg Psychiatry 1992; 55: 640-52.
45. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Long-term risk of first recurrent stroke in the Perth Community Stroke Study. Stroke 1998; 29: 2491-500.
46. Herderschee D, Hijdra A, Algra A, Koudstaal PJ, Kappelle LJ, van Gijn J. Silent stroke in patients with transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. Stroke 1992; 23: 1220-4.
47. Herskovits E, Vazquez A, Famulari A, Smud R, Tamaroff L, Fraiman H, et al. Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks. Lancet 1981a; i: 966-8.
48. Herskovits E, Vazquez A, Famulari A, Tamaroff L, Fraiman H, Gonzales AM, et al. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up. Ric Clin Lab 1981b; 11 Suppl 1: 257-64.
49. Heyden S. Spontanverlauf zerebrovaskulärer ischämischer Attacken (TIA). Aktuelle Neurol 1979; 6: 119-34.
50. Heyman A, Gore T, Wilkinson WE, Hurwitz BJ, Burch JG, Haynes CS, et al. TIA with benign outcome [abstract]. Stroke 1982; 13: 112.
51. Heyman A, Wilkinson WE, Hurwitz BJ, Haynes CS, Utley CM, Rosati RA, et al. Risk of ischemic heart disease in patients with TIA. Neurology 1984a; 34: 626-30.
52. Heyman A, Wilkinson WG, Hurwitz BJ, Haynes CS, Utley CM. Clinical and epidemiologic aspects of vertebrobasilar and nonfocal cerebral ischemia. In: Berguer R, Bauer RB, editors. Vertebrobasilar arterial occlusive disease. New York: Raven Press; 1984b. p. 27-36.
53. Howard G, Toole JF, Frye-Pierson J, Hinshelwood LC. Factors influencing the survival of 451 transient ischemic attack patients. Stroke 1987; 18: 552-7.
54. Keith DS, Phillips SJ, Whisnant JP, Nishimaru K, O'Fallon WM. Heparin therapy for recent transient focal cerebral ischemia. Mayo Clin Proc 1987; 62: 1101-6.
55. Kernan WN, Feinstein AR, Brass LM. A methodological appraisal of research on prognosis after transient ischemic attacks. Stroke 1991; 22: 1108-16.
56. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 1999; 30: 1174-80.
57. Koudstaal PJ, van Gijn J, Frenken CWGM, Hijdra A, Lodder J, Vermeulen M, et al. TIA, RIND, minor stroke: a continuum, or different subgroups? Dutch TIA Study Group. J Neurol Neurosurg Psychiatry 1992; 55: 95-7.
58. Larsen BH, Sørensen PS, Marquardsen J. Transient ischaemic attacks in young patients: a thromboembolic or migrainous manifestation? A 10 year follow up study of 46 patients. J Neurol Neurosurg Psychiatry 1990; 53: 1029-33.
59. Lee TK, Lien IN, Ryu SJ, Lee KY, Hu HH, Tchen PH, et al. Secondary prevention of ischemic stroke with low dose acetylsalicylic acid. J Formos Med Assoc 1990; 89: 635-44.
60. López-Gastón JI, Martín J, Errea JM, Bertol V, Pina MA. AIT. Evolutión y seguimiento. Rev Esp Neurol 1994; 9: 75-80.
61. Marini C, Totaro R, Carolei A. Long-term prognosis of cerebral ischemia in young adults. National Research Council Study Group on Stroke in the Young. Stroke 1999; 30: 2320-5.
62. Marshall J. The natural history of transient ischaemic cerebrovascular attacks. Q J Med 1964; 33: 309-24.
63. Marshall J, Reynolds EH. Withdrawal of anticoagulants from patients with transient ischaemic cerebrovascular attacks. Lancet 1965; i: 5-6.
64. Martin PJ. Vertebrobasilar ischaemia. Q J Med 1998; 91: 799-811.
65. Matias-Guiu J, Davalos A, Pico M, Monasterio J, Vilaseca J, Codina A. Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks. Acta Neurol Scand 1987; 76: 413-21.
66. McDowell FH, Potes J, Groch S. The natural history of internal carotid and vertebral-basilar artery occlusion. Neurology 1961; 11: 153-7.
67. Mead GE, Lewis SC, Wardlaw JM, Dennis MS. Comparison of risk factors in patients with transient and prolonged eye and brain ischemic syndromes. Stroke 2002; 33: 2383-90.
68. Mohr JP, Gautier JC, Pessin MS. Internal carotid artery disease. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, editors. Stroke. 2nd ed. New York: Churchill Livingstone; 1992. p. 311.
69. Murros KE, Evans GW, Toole JF, Howard G, Rose LA. Cerebral infarction in patients with transient ischemic attacks. J Neurol 1989; 236: 182-4.
70. Muuronen A, Kaste M. Outcome of 314 patients with transient ischemic attacks. Stroke 1982; 13: 24-31.
71. Olsson JE, Müller R, Berneli S. Long-term anticoagulant therapy for TIAs and minor strokes with minimum residuum. Stroke 1976; 7: 444-51.
72. Olsson J-E, Brechter C, Bäcklund H, Krook H, Müller R, Nitelius E, et al. Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks. Stroke 1980; 11: 4-9.
73. Omae T. Natural history of transient cerebral ischaemia as observed among the Japanese. In: Hatano S, Shigematsu I, Strasser T, editors. Hypertension and stroke control in the population. Proceedings of a WHO meeting held in Tokyo, 11-13 March 1974. Geneva: WHO; 1976. p. 284-9.
74. Ostfeld AM, Shekelle RB, Klawans HL. Transient ischemic attacks and risk of stroke in an elderly poor population. Stroke 1973; 4: 980-6.
75. Prencipe M, Culasso F, Rasura M, Anzini A, Beccia M, Cao M, et al. Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort. Stroke 1998; 29: 126-32.
76. Puranen J, Laakso M, Riekkinen P, Sivenius J. Risk factors and antiplatelet therapy in TIA and stroke patients. J Neurol Sci 1998; 154: 200-4.
77. Putman SF, Adams HP Jr. Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol 1985; 42: 960-2.
78. Reuther R, Domdorf W, Loew D. Behandlung transitorisch-ischämischer Attacken mit Aazetylsalizylsäure. MMW Münch Med Wochenschr 1980; 122: 795-8.
79. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price T. Determinants of early recurrence of cerebral infarction: The Stroke Data Bank. Stroke 1989; 20: 983-9.
80. Siekert RG, Millikan CH, Whisnant JP. Anticoagulant therapy in intermittent cerebrovascular insufficiency. JAMA 1961; 176: 19-22.
81. Simonsen N, Christiansen HD, Heltberg A, Marquardsen J, Pedersen HE, Sørensen PS. Long-term prognosis after transient ischemic attacks. Acta Neurol Scand 1981; 63: 156-68.
82. Sivenius J, Riekkinen PJ, Smets P, Laakso M, Lowenthal A. The European Stroke Prevention Study (ESPS): results by arterial distribution. Ann Neurol 1991; 29: 596-600.
83. Sørensen PS, Pedersen H, Marquardsen J, Petersson H, Heltberg A, Simonsen N, et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible ischemic attacks. Stroke 1983; 14: 15-22.
84. Sørensen PS, Marquardsen J, Pedersen H, Heltberg A, Munck O. Long-term prognosis and quality of life after reversible cerebral ischemic attacks. Acta Neurol Scand 1989; 79: 204-13.
85. Sterne JAC, Bradburn MJ, Egger M. Dealing with zero cells. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care. Meta-analysis in context. 2nd ed. London: BMJ; 2001. p. 375-6.
86. Streifler JY, Eliasziw M, Benavente OR, Harbison JW, Hachinski VC, Barnett HJ, et al. The risk of stroke in patients with first-ever retinal vs hemispheric transient ischemic attacks and high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol 1995; 52: 246-9.
87. Toole JF, Yuson CP, Janeway R, Johnston F, Davis C, Cordell AR, et al. Transient ischemic attacks: a prospective study of 225 patients. Neurology 1978; 28: 746-53.
88. Tsuda Y, Kimura K, Yoneda S, Miyai M, Isaki Y, Abe H. Transient ischemic attacks: racial differences, treatment, and prognosis. Neurol Res 1983; 5: 103-17.
89. Turney T, Garraway WM, Whisnant JP. The natural history of hemispheric and brainstem infarction in Rochester, Minnesota. Stroke 1984; 15: 790-4.
90. Ueda K, Kiyohara Y, Hasuo Y, Yanai T, Kawano H, Wada J, et al. Transient cerebral ischemic attacks in a Japanese population, Hisayama, Japan. Stroke 1987; 18: 844-8.
91. Whisnant JP, Wiebers DO. Clinical epidemiology of transient cerebral ischaemic attacks (TIA) in the anterior and posterior cerebral circulation. In: Sundt TM, editor. Occlusive cerebrovascular disease, diagnosis and surgical management. Philadelphia: Saunders; 1987. p. 60-5.
92. Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc 1973; 48: 194-8.
93. Whisnant JP, Cartlidge NE, Elveback LR. Carotid and vertebral-basilar transient ischemic attacks: effect of anticoagulants, hypertension, and cardiac disorders on survival and stroke occurrence - a population study. Ann Neurol 1978; 3: 107-15.
94. Wiebers DO, Whisnant JP, O'Fallon WM. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974. Neurology 1982; 32: 459-65.
95. Ziegler DK, Hassanein RS. Prognosis in patients with transient ischemic attacks. Stroke 1973; 4: 666-73.